期刊文献+

卡托普利对内皮细胞分泌组织型纤溶酶原激活物和纤溶酶原激活物抑制剂-1的影响

The effects of captopril on endothelial cell secreting of t-PA and PAI-1
下载PDF
导出
摘要 目的:研究转换酶抑制剂卡托普利对内皮细胞组织型纤溶酶原激活物(t-PA)和纤溶酶原激活物抑制剂-1 (PAI-1)的影响。方法:培养肺静脉内皮细胞(ECV304),分别用肿瘤坏死因子(TNF)-α(浓度为5、10、25、50、100 μg/L)和血管紧张素Ⅱ(AngⅡ)(5、10、25、50、100 nmol/L)刺激,在50μg/L TNF-α刺激的基础上用卡托普利(20、50、100、200 nmol/L)共育,用ELISA的方法检测培养上清中的t-PA和PAI-1的浓度。结果:各浓度的TNF-α和AngⅡ刺激24 h后PAI-1的浓度明显增加,与空白对照相比P<0.05,而t-PA的差异则无统计学意义;各浓度的卡托普利明显抑制TNF-α(50μg/L)诱导的PAI-1分泌增多,P<0.05,而t-PA的变化不明显。结论:TNF-α和AngⅡ可以增加内皮细胞PAI-1的分泌,卡托普利可以抑制TNF-α诱导PAI-1的分泌,而t-PA则不受TNF-α、AngⅡ和卡托普利等因素影响。 Objective: To investigate the effects of captopril on fibrolytic balance. Methods: Cultivated ECV304 cells were stimulated with TNF-α(5,10,25,50,100 μg)and AngⅡ(5,10,25,50,100 nmol/L) for 24 hours. The same cells were also co-incubated with TNF-α(ng/ml)and captopril(20,50,100,200 nmol/L). Tissue-type plasminogen activator(t-PA) and plasminogen activator inhibitor-1 (PAI-1) in the supernatant were measured by enzyme linked immunosorbent assay (ELISA). Results: The concentrations of t-PA had no statistically significant changes in all supernatant of cultivated cells. But PAI-1 was significantly increased by Ang Ⅱ and TNF-α at same concentration. The PAI-1 secreting, induced by TNF-α, can be inhibited by captopril. Conclusion: Captopril has no effect on t-PA releasing from endo-thelial cells. TNF-α can increase PAI-1 secreting, but captopril can counteract this effect.
出处 《医学研究生学报》 CAS 2005年第B05期1-2,6,共3页 Journal of Medical Postgraduates
关键词 卡托普利 组织型纤溶酶原激活物 纤溶酶原激活物抑制剂-1 Captopril Tissue plasminogen activator Plasminogen activator inhibitor-1
  • 相关文献

参考文献8

  • 1Douglas EV. Angiotensin, Fibrinolysis, and Vascular Homeostasis[J]. Am J Cardiol, 2001,87(Suppl): 18C-24C.
  • 2Brown NJ, Gainer JV, Stein CV et al. Bradykinin stimulates tissue plasminogen activator release in human vasculature [ J ]. Hypertension, 1999, 33(6): 1431-1435.
  • 3Vaughan DE. The rennin-angiotensin system and fibrinolysis [J].Am J Cardiol, 1997, 79(5A): 12-16.
  • 4Nakamura S, Nakamura I, Ma C et al. Plasminogen activator inhibitor-1 expression is regulated by the angiotensin type 1 receptor in vivo[J]. Kidney Int, 2000, 58(1): 251-259.
  • 5Kerins DM, Hao Q, Vaughan DE et al. Angiotensin induction of PAI-1 expression in endothelialcells is mediated by the hexapeptide angiotensin IV[J]. J Clin Invest, 1995, 96(5): 2515-2520.
  • 6Lupu F, Heim DA, Bachmaan F et al. Plasminogen activator expression in human atherosclerotic lesions[ J]. Arterioscler Thromb Vasc Biol, 1995, 15(9): 1444-1455.
  • 7Carmeliet P, Moons L, Lijnen R et al. Inhibitory role of plasminogen activator inhibitor-1 in arterial wound healing and neointima formation: a gene targeting and gene transfer study in mice [J].Circulation, 1997, 96(9): 3180-3191.
  • 8Bell L, Luthringer DJ, Madri JA et al. Autocrine angiotensin system regulation of bovine aortic endothelial cell migration and plasminogenactivator involves modulation of proto-oncogen expression[J]. J Clin Invest, 1992, 89(1): 315-320.

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部